As per MRFR analysis, the India Personalized Medicine Market Size was estimated at 27.83 (USD Billion) in 2023.The India Personalized Medicine Market is expected to grow from 29.84(USD Billion) in 2024 to 80.0 (USD Billion) by 2035. The India Personalized Medicine Market CAGR (growth rate) is expected to be around 9.381% during the forecast period (2025-2035).
Key India Personalized Medicine Market Trends Highlighted
The market for personalized medicine in India is undergoing revolutionary changes due to developments in biotechnology and genomics. The expanding understanding of the significance of customizing therapies to each patient's unique genetic profile, which results in more efficient healthcare solutions, is driving the increased acceptance of precision medicine.
In order to improve the field of customized medicine, the Indian government has taken the initiative to support biotechnology research and development and to build partnerships between the public and commercial sectors.
This dedication is demonstrated by the National Biotechnology Development Strategy, which establishes India as a center for healthcare innovation. The accuracy of disease detection and treatment routes is being improved by recent trends showing an increase in the demand for molecular diagnostics and genetic testing in India.
Telemedicine and mobile health platforms are helping patients, especially those in rural and semi-urban regions, receive individualized medicine as a result of the strong push toward digital health solutions.
Additionally, new potential for patient data analysis, treatment method improvement, and result prediction are being made possible by the integration of big data and artificial intelligence in healthcare systems.
This industry offers a lot of potential, particularly in areas where the prevalence of chronic illnesses like diabetes and cancer is high. In these areas, personalized medicine can have a significant impact on patient outcomes and management.
Innovation in tailored therapeutics depends on the continuous partnerships between Indian healthcare providers and research organizations. The potential to use this trend to create individualized treatment regimens is clear as patients and healthcare professionals become more aware of customized medicine.
For the personalized medicine market in India to flourish as the healthcare environment changes, regulatory issues must be resolved, and infrastructure must be improved.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Personalized Medicine Market Drivers
Increasing Prevalence of Chronic Diseases
The rising incidence of chronic diseases, particularly cancer, cardiovascular diseases, and diabetes, is significantly boosting the growth of the India Personalized Medicine Market.
According to the National Institute of Cancer Prevention and Research, the number of cancer cases in India is expected to rise from 14 lakh in 2020 to an estimated 29 lakh by 2040. This continuous increase puts pressure on the healthcare system and drives the demand for personalized medicine strategies that target the unique genetic make-up of patients for more effective treatment.
Organizations like the Tata Memorial Centre are at the forefront, utilizing personalized medicine approaches for treating cancer, thereby impacting treatment outcomes and pushing for innovations within the industry.
As the number of patients requiring tailored therapies increases, the viability and attractiveness of the India Personalized Medicine Market grow, making it a focal area for investment and development.
Advancements in Genomic Research
The rapid advancements in genomic research and technology are propelling the India Personalized Medicine Market. With a growing number of genomic sequencing projects, such as the Indian Genome Variation project, which has mapped the genetic variation across diverse Indian populations, there's an increasing pool of data available for developing customized treatments.
The Indian government has been supportive of this by funding various genomic medicine initiatives, which has led to a pronounced rise in precision medicine applications in healthcare. According to recent data from the Department of Biotechnology, the sector could see a surge in companies leveraging genomic data for developing medications, which reinforces the impact on personalized medicine strategies.
Supportive Government Initiatives and Policies
The Indian government's proactive initiatives to promote healthcare innovation directly impact the India Personalized Medicine Market.
For instance, the 'National Health Mission' and 'Ayushman Bharat' schemes emphasize advancements in healthcare technology and affordable treatment for all. Supported by the Biotechnology Industry Research Assistance Council (BIRAC), these initiatives aim to foster growth in the biotech and personalized medicine sector.
With more than 500 biotech startups emerging in India due to policies promoting research and development, the government is creating a conducive environment for personalized medicine to thrive, thus significantly boosting the industry's prospects in personalized therapeutics.
Growing Awareness and Acceptance of Personalized Medicine
There is an increasing awareness and acceptance of personalized medicine among healthcare professionals and patients in India. Educational campaigns led by organizations like the Indian Medical Association have been effective in disseminating knowledge about the benefits of targeted therapies and precision medicine.
According to surveys, approximately 70% of healthcare providers in urban areas are now recognizing the importance of personalized treatment plans, illustrating a shift in treatment paradigms.
This cultural shift is crucial as it drives demand for personalized medical solutions, leading to heightened growth within the India Personalized Medicine Market. The increasing willingness of patients to engage in therapies tailored to their individual genetic profiles indicates a growing trust in the capabilities of personalized medicine.
India Personalized Medicine Market Segment Insights
Personalized Medicine Market Product Outlook Insights
The India Personalized Medicine Market offers a diverse range of products that meet the evolving healthcare needs of the population, particularly through its Product Outlook segment. This segment includes critical pathways such as Personalized Medicine Diagnostics, which plays a vital role in early disease detection and tailored treatment strategies for patients.
Personalized Medicine Therapeutics focuses on improving treatment efficacy by utilizing genetic and molecular insights, thereby personalizing drug responses and minimizing adverse effectsa necessity in a diverse nation like India with its varied genetic profiles.
Furthermore, Personalized Medical Care emphasizes the holistic approach to patient management, targeting both physical and mental health tailored to individual conditions and lifestyle choices.
In addition, Personalized Nutrition and Wellness addresses the growing awareness of health optimization through customized dietary recommendations, which resonate strongly with the increasing health-conscious segment of the Indian population.
This growing interest reflects a broader trend toward preventive healthcare, highlighting the importance of personalized solutions in addressing chronic disease management and enhancing overall wellness.
Overall, these interconnected areas are shaped by advancements in technology, increasing healthcare access, and rising consumer awareness, which collectively drive innovation and growth within the India Personalized Medicine Market, creating a substantial opportunity for stakeholders in the healthcare ecosystem.
The market dynamics are further influenced by government initiatives aimed at promoting personalized healthcare solutions, aligning with broader health objectives to improve outcomes for a diverse demographic, thereby showcasing the evident growth and potential across these critical product areas.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Personalized Medicine Market Application Outlook Insights
The India Personalized Medicine Market within the Application Outlook segment is experiencing robust growth, driven by advancements in technology and increased healthcare spending. The oncology segment holds a significant share, as personalized therapies are increasingly recognized for their effectiveness in targeting cancer, which is a leading cause of mortality in India.
The growing prevalence of chronic diseases further emphasizes the need for tailored treatment approaches. Central Nervous System (CNS) disorders also present substantial opportunities, given the rising incidence of mental health issues and neurodegenerative diseases.
Immunology is expanding as precision medicine plays a pivotal role in managing autoimmune diseases and enhancing vaccine efficacy, which is particularly relevant given India's diverse genetic landscape. The respiratory segment is gaining attention due to the alarming air quality issues in many cities, and personalized treatments are critical for effectively managing conditions such as asthma and COPD.
Lastly, the "Others" category encompasses various innovative applications, indicating the versatility of personalized medicine in addressing different healthcare needs. Overall, the segmentation within the India Personalized Medicine Market highlights a dynamic landscape with significant opportunities for enhancing patient outcomes through tailored therapies.
Personalized Medicine Market End-User Outlook Insights
The India Personalized Medicine Market is significantly influenced by various end-user segments, including Hospitals, Diagnostic Centers, Research Academic Institutes, and Others. Hospitals serve as a critical hub for personalized medicine, leveraging advanced technologies to tailor treatments to individual patient profiles, ensuring better outcomes and higher patient satisfaction.
Similarly, Diagnostic Centers play a vital role by enabling precise diagnostics, which is foundational in the development of personalized treatments, making them essential to this evolving market landscape. Research Academic Institutes are at the forefront of innovation in personalized medicine, driving breakthroughs through extensive studies and trials.
These institutions collaborate with industry players to enhance the overall understanding and application of personalized therapies. Other end-users also contribute to the market dynamics, including specialty clinics and home healthcare services, creating a diverse ecosystem that supports the growing demand for personalized medicine solutions.
The growing population and increasing prevalence of chronic diseases in India are substantial growth drivers for these segments, while challenges such as regulatory hurdles and high costs of personalized therapies present opportunities for major innovations within the market.
The India Personalized Medicine Market segmentation underscores the need for tailored approaches in healthcare, aligning seamlessly with the nation's push towards advanced medical solutions.
India Personalized Medicine Market Key Players and Competitive Insights
The India Personalized Medicine Market is rapidly evolving, driven by advancements in genomics, biotechnology, and healthcare technology. As healthcare shifts from a one-size-fits-all approach to more individualized treatment options, the competitive landscape of this market is becoming increasingly dynamic.
Several companies are vying for market share, focusing on innovative solutions tailored to specific patient needs. The competition is characterized by a blend of established pharmaceutical giants and emerging biotech firms, all seeking to capitalize on the growing demand for personalized treatments.
Given the vast diversity in the Indian population and the associated health challenges, firms are continuously investing in research and development to refine their offerings.
Collaboration with academic institutions and healthcare providers is also a strategy employed to stay ahead in this competitive race, ensuring that products are not only scientifically validated but also meet the regulatory standards set forth by health authorities.
Myntra, while primarily known as an e-commerce platform, is diversifying its portfolio to include various lifestyle and health initiatives, thereby entering the realm of personalized medicine within India. The company boasts strengths in its extensive customer base and data analytics capabilities, utilizing consumer insights to inform and personalize health-related product offerings.
With a strong focus on enhancing user experience through technology, Myntra has the potential to connect personalized medicine solutions to a broader audience, tapping into existing data to recommend tailored health products. Additionally, the company's supply chain and logistics capabilities enable it to efficiently deliver specialized health products, reinforcing its competitive edge in this emerging market.
Biocon stands out in the India Personalized Medicine Market as a major player focusing on biopharmaceutical innovations. Known for its robust portfolio of biotech products, Biocon places a significant emphasis on providing affordable biosimilars that cater to personalized treatment protocols for chronic diseases.
The company's key offerings include monoclonal antibodies and recombinant proteins, which are pivotal in the delivery of targeted therapies. Biocon has established a strong market presence through various strategic collaborations and alliances with global companies, tapping into broader synergies for drug development.
Moreover, its recent mergers and acquisitions have strengthened its capabilities and expanded its reach in the personalized medicine domain.
This strategic positioning, coupled with consistent investment in research and development, has enabled Biocon to cater to the unique healthcare needs of the Indian population, bolstering its reputation as a leader in biopharmaceutical innovations in the personalized medicine sector.
Key Companies in the India Personalized Medicine Market Include
India Personalized Medicine Market Developments
Recent developments in the India Personalized Medicine Market highlight significant advancements and strategic movements among key players. In October 2023, Biocon announced a collaboration with a leading biotechnology firm to develop next-generation biosimilars, aiming to enhance patient outcomes through personalized therapies.
HealthCare Global Enterprises launched a personalized cancer care program to tailor treatment plans based on genetic profiles, reflecting the urgent need for precision in oncology.
In September 2023, Mylab Discovery Solutions expanded its offerings with new diagnostic tests focusing on genetic markers, showcasing a trend toward integrating genomics with routine clinical practice. Additionally, Dr. Lal PathLabs reported a partnership with the government to extend genetic testing capabilities across rural areas, enhancing accessibility.
Furthermore, Strand Life Sciences and MedGenome are actively involved in developing AI-driven diagnostic solutions, indicating a growing intersection of technology and personalized medicine.
Over the past two years, numerous companies have seen significant market valuation growth due to these innovations, reflecting an increasing recognition of the importance of personalized treatments in India's healthcare landscape. The government's push for improved healthcare infrastructure also supports this burgeoning market, underscoring its vital role in future medical advancements.
India Personalized Medicine Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 27.83(USD Billion) |
| MARKET SIZE 2024 | 29.84(USD Billion) |
| MARKET SIZE 2035 | 80.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.381% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Myntra, Biocon, Syngene International, Dr. Lal PathLabs, HealthCare Global Enterprises, Mylab Discovery Solutions, Genes2Me, Cellix Bio, MedGenome, Nalanda Diagnostics, Mapmygenome, Egenes, Strand Life Sciences, Omicsx, Qure.ai |
| SEGMENTS COVERED | Product Outlook, Application Outlook, End-User Outlook |
| KEY MARKET OPPORTUNITIES | Growing demand for targeted therapies, Increasing genomic research investments, Expanding bioinformatics solutions market, Rising prevalence of chronic diseases, Government initiatives supporting healthcare innovation |
| KEY MARKET DYNAMICS | increasing demand for targeted therapies , rising prevalence of chronic diseases , advancements in genomic technologies , growing investments in healthcare innovation , supportive regulatory frameworks |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Personalized Medicine Market is expected to be valued at approximately 29.84 USD Billion in 2024.
By 2035, the India Personalized Medicine Market is projected to reach a value of 80.0 USD Billion.
The expected compound annual growth rate for the India Personalized Medicine Market from 2025 to 2035 is 9.381%.
In 2024, the Personalized Medicine Therapeutics segment is valued the highest at 10.8 USD Billion.
The Personalized Medicine Diagnostics segment is projected to be valued at 21.47 USD Billion by 2035.
Key players in the market include Biocon, Syngene International, and Dr. Lal PathLabs among others.
The Personalized Medical Care segment is projected to be valued at 5.64 USD Billion in 2024.
The Personalized Nutrition and Wellness segment is anticipated to reach a value of 14.94 USD Billion by 2035.
Growing demand for personalized treatment options coupled with advancements in technology presents ample growth opportunities.
Challenges in the market include regulatory hurdles and the need for substantial investment in research and development.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
| FEATURES | LICENCE TYPE | ||
|---|---|---|---|
| Single User | Multiuser Licence | Enterprise User | |
| Price | $ 4,950 | $ 5,950 | $ 7,250 |
| Maximum User Access Limit | 1 User | Upto 10 Users | Unrestricted Access Throughout The Organization. |
| Free Customization |  |
|
|
| Direct access to the Analyst | |
|
|
| Deliverable Format | |
|
|
 |
|
|
|
| Platform Access | |
|
|
| Discount on Your Next Purchase | 10% | 15% | 10% |
| Printable Versions | |
|
|
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
